Vardarajan, B. N., Reyes‐Dumeyer, D., Piriz, A. L., Lantigua, R. A., Medrano, M., Rivera, D., Jiménez‐Velázquez, I. Z., Martin, E., Pericak‐Vance, M. A., Bush, W., Farrer, L., Haines, J. L., Wang, L., Leung, Y. Y., Schellenberg, G., Kukull, W., De Jager, P., Bennett, D. A., Schneider, J. A., … Mayeux, R. (2022). Progranulin mutations in clinical and neuropathological Alzheimer’s disease. Alzheimer’s & Dementia, 18(12), 2458–2467. Portico. https://doi.org/10.1002/alz.12567

Ro, V., Jones, T., Silverman, T., McGuinness, J. E., Guzman, A., Amenta, J., Kukafka, R., & Crew, K. D. (2022). Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09900-x

Pablos-Méndez, A., Villa, S., Monti, M. C., Raviglione, M. C., Tabish, H. B., Evans, T. G., & Cash, R. A. (2022). Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West.” Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-09286-7

Oussalah, A., Siblini, Y., Hergalant, S., Chéry, C., Rouyer, P., Cavicchi, C., Guerrini, R., Morange, P.-E., Trégouët, D., Pupavac, M., Watkins, D., Pastinen, T., Chung, W. K., Ficicioglu, C., Feillet, F., Froese, D. S., Baumgartner, M. R., Benoist, J.-F., Majewski, J., … Guéant, J.-L. (2022). Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B12. Clinical Epigenetics, 14(1). https://doi.org/10.1186/s13148-022-01271-1

Curiel-Garcia, A., Decker-Farrell, A. R., Sastra, S. A., & Olive, K. P. (2022). Generation of orthotopic patient-derived xenograft models for pancreatic cancer using tumor slices. STAR Protocols, 3(4), 101899. https://doi.org/10.1016/j.xpro.2022.101899

Reza, N., Nayak, A., Lewsey, S. C., & DeFilippis, E. M. (2022). Representation matters: a call for inclusivity and equity in heart failure clinical trials. European Heart Journal Supplements, 24(Supplement_L), L45–L48. https://doi.org/10.1093/eurheartjsupp/suac115

Liu, S., Leone, M., Ludvigsson, J. F., Lichtenstein, P., Gudbjörnsdottir, S., Landén, M., Bergen, S. E., Taylor, M. J., Larsson, H., Kuja-Halkola, R., & Butwicka, A. (2022). Early-Onset Type 2 Diabetes and Mood, Anxiety, and Stress-Related Disorders: A Genetically Informative Register-Based Cohort Study. Diabetes Care, 45(12), 2950–2956. https://doi.org/10.2337/dc22-1053

Han, D., Rozanski, A., Miller, R. J. H., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Liang, J. X., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry. Journal of Nuclear Cardiology, 29(6), 3221–3232. https://doi.org/10.1007/s12350-021-02829-x

González, B. J., Zhao, H., Niu, J., Williams, D. J., Lee, J., Goulbourne, C. N., Xing, Y., Wang, Y., Oberholzer, J., Blumenkrantz, M. H., Chen, X., LeDuc, C. A., Chung, W. K., Colecraft, H. M., Gromada, J., Shen, Y., Goland, R. S., Leibel, R. L., & Egli, D. (2022). Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03696-z

Watabayashi, K. K., Bell-Brown, A., Kreizenbeck, K., Egan, K., Lyman, G. H., Hershman, D. L., Arnold, K. B., Bansal, A., Barlow, W. E., Sullivan, S. D., & Ramsey, S. D. (2022). Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07835-4

Yamabe, T., Ginns, J., Vedula, V., Leb, J. S., Shimada, Y. J., Weiner, S. D., & Takayama, H. (2022). REPLY FROM AUTHORS: Septal myectomy performed along the “septal band.” JTCVS Techniques, 16, 70–71. https://doi.org/10.1016/j.xjtc.2022.08.013

Carabuena, T. J., Boege, H. L., Bhatti, M. Z., Whyte, K. J., Cheng, B., & St‐Onge, M. (2022). Delaying mealtimes reduces fat oxidation: A randomized, crossover, controlled feeding study. Obesity, 30(12), 2386–2395. Portico. https://doi.org/10.1002/oby.23566

Doulamis, I. P., Tzani, A., Kourek, C., Kampaktsis, P. N., Inampudi, C., Kilic, A., & Briasoulis, A. (2022). Sex mismatch following heart transplantation in the United States: Characteristics and impact on outcomes. Clinical Transplantation, 36(12). Portico. https://doi.org/10.1111/ctr.14804

Han, D., Rozanski, A., Gransar, H., Tzolos, E., Miller, R. J. H., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Liang, J. X., Hu, L.-H., Dey, D., Berman, D. S., & Slomka, P. J. (2022). Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry. Journal of Nuclear Cardiology, 29(6), 3003–3014. https://doi.org/10.1007/s12350-021-02810-8

Sun, J., Fang, F., Olén, O., Song, M., Halfvarson, J., Roelstraete, B., Khalili, H., & Ludvigsson, J. F. (2022). Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09992-5

Zhu, W., Ding, C., Huang, P., Ran, J., Lian, P., Tang, Y., Dai, W., & Huang, X. (2022). Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-09610-1

Lee, S., Mazur, S., Mazur, S., Kodiyanplakkal, R. P., Theodore, D., & Kubin, C. J. (2022). 892. Clinical Impact of Early Antifungal De-escalation (≤ 2 days) based on Rapid Species Identification in Patients with Azole-susceptible Candidemia. Open Forum Infectious Diseases, 9(Supplement_2). https://doi.org/10.1093/ofid/ofac492.737

Yu, J., & Pajvani, U. B. (2022). Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma. Medical Review, 2(6), 544–546. https://doi.org/10.1515/mr-2022-0043

Yeoh, B. S., Saha, P., Golonka, R. M., Zou, J., Petrick, J. L., Abokor, A. A., Xiao, X., Bovilla, V. R., Bretin, A. C. A., Rivera-Esteban, J., Parisi, D., Florio, A. A., Weinstein, S. J., Albanes, D., Freeman, G. J., Gohara, A. F., Ciudin, A., Pericàs, J. M., Joe, B., … Vijay-Kumar, M. (2022). Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer. Gastroenterology, 163(6), 1658-1671.e16. https://doi.org/10.1053/j.gastro.2022.08.033

Blair, C., Slee, A., Davenport, A., Fouque, D., Johnston, W., Kalantar-Zadeh, K., Maxwell, P., McKeaveney, C., Mullan, R., Noble, H., Porter, S., Seres, D., Shields, J., Swaine, I., Witham, M., & Reid, J. (2022). Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change. Healthcare, 10(12), 2344. https://doi.org/10.3390/healthcare10122344

Ling, R. R., Ramanathan, K., Sim, J. J. L., Wong, S. N., Chen, Y., Amin, F., Fernando, S. M., Rochwerg, B., Fan, E., Barbaro, R. P., MacLaren, G., Shekar, K., & Brodie, D. (2022). Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis. Critical Care, 26(1). https://doi.org/10.1186/s13054-022-04011-2

Eleid, M. F., Wang, D. D., Pursnani, A., Kodali, S. K., George, I., Palacios, I., Russell, H., Makkar, R. R., Kar, S., Satler, L. F., Rajagopal, V., Dangas, G., Tang, G. H. L., McCabe, J. M., Whisenant, B. K., Fang, K., Kaptzan, T., Lewis, B., Douglas, P., … Guerrero, M. E. (2022). 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. Journal of the American College of Cardiology, 80(23), 2171–2183. https://doi.org/10.1016/j.jacc.2022.09.037

Wan, Q., Huang, B., Li, T., Xiao, Y., He, Y., Du, W., Wang, B. Z., Dakin, G. F., Rosenbaum, M., Goncalves, M. D., Chen, S., Leong, K. W., & Qiang, L. (2022). Selective targeting of visceral adiposity by polycation nanomedicine. Nature Nanotechnology, 17(12), 1311–1321. https://doi.org/10.1038/s41565-022-01249-3

Keshavjee, S. H., Moy, R. H., Reiner, S. L., Ryeom, S. W., & Yoon, S. S. (2022). Gastric Cancer and the Immune System: The Key to Improving Outcomes? Cancers, 14(23), 5940. https://doi.org/10.3390/cancers14235940

Davidson, L. J., Cleveland, J. C., Welt, F. G., Anwaruddin, S., Bonow, R. O., Firstenberg, M. S., Gaudino, M. F., Gersh, B. J., Grubb, K. J., Kirtane, A. J., Tamis-Holland, J. E., Truesdell, A. G., Windecker, S., Taha, R. A., & Malaisrie, S. C. (2022). A Practical Approach to Left Main Coronary Artery Disease. Journal of the American College of Cardiology, 80(22), 2119–2134. https://doi.org/10.1016/j.jacc.2022.09.034

Baik, J. E., Li, L., Shah, M. A., Freedberg, D. E., Jin, Z., Wang, T. C., & Han, Y. W. (2022). Circulating IgA Antibodies AgainstFusobacterium nucleatumAmyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer Research Communications, 2(11), 1497–1503. https://doi.org/10.1158/2767-9764.crc-22-0248

Song, L., Xu, B., Tu, S., Guan, C., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Yang, J., Liu, X., Guo, L., Shen, C., Zhang, Y., Zhang, Q., … Stone, G. W. (2022). 2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions. Journal of the American College of Cardiology, 80(22), 2089–2101. https://doi.org/10.1016/j.jacc.2022.09.007

Das Pradhan, A., Glynn, R. J., Fruchart, J.-C., MacFadyen, J. G., Zaharris, E. S., Everett, B. M., Campbell, S. E., Oshima, R., Amarenco, P., Blom, D. J., Brinton, E. A., Eckel, R. H., Elam, M. B., Felicio, J. S., Ginsberg, H. N., Goudev, A., Ishibashi, S., Joseph, J., Kodama, T., … Ridker, P. M. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New England Journal of Medicine, 387(21), 1923–1934. https://doi.org/10.1056/nejmoa2210645

Shi, H., Wang, X., Li, F., Gerlach, B. D., Yurdagul, A., Moore, M. P., Zeldin, S., Zhang, H., Cai, B., Zheng, Z., Valenti, L., & Tabas, I. (2022). CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Science Translational Medicine, 14(672). https://doi.org/10.1126/scitranslmed.abp8309

Li, D., Yang, J., Malik, V., Huang, Y., Huang, X., Zhou, H., & Wang, J. (2022). An RNAi screen of RNA helicases identifies eIF4A3 as a regulator of embryonic stem cell identity. Nucleic Acids Research, 50(21), 12462–12479. https://doi.org/10.1093/nar/gkac1084

Babajide, O. (2022). Clinical characteristics, predictors, and rates of hospitalized acute cholangitis patients in the United States. Annals of Gastroenterology. https://doi.org/10.20524/aog.2022.0756

Yoshida, Y., Nakanishi, K., Daimon, M., Hirose, K., Ishiwata, J., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., Di Tullio, M. R., Homma, S., & Komuro, I. (2022). Aortic valve sclerosis and subclinical left ventricular dysfunction in the general population with normal left ventricular geometry. European Journal of Preventive Cardiology, 30(6), 454–460. https://doi.org/10.1093/eurjpc/zwac279

Lee, K. E., Cantrell, S., Shen, B., & Faye, A. S. (2022). Post-operative prevention and monitoring of Crohn’s disease recurrence. Gastroenterology Report, 10. https://doi.org/10.1093/gastro/goac070

Tropea, M. R., Gulisano, W., Vacanti, V., Arancio, O., Puzzo, D., & Palmeri, A. (2022). Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease. Free Radical Biology and Medicine, 193, 657–668. https://doi.org/10.1016/j.freeradbiomed.2022.11.022

Scotti, A., Sturla, M., Granada, J. F., Kodali, S. K., Coisne, A., Mangieri, A., Godino, C., Ho, E., Goldberg, Y., Chau, M., Jorde, U. P., Garcia, M. J., Maisano, F., Bapat, V. N., Ailawadi, G., & Latib, A. (2022). Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies. EuroIntervention, 18(10), 840–851. https://doi.org/10.4244/eij-d-22-00442

Laleu, B., Rubiano, K., Yeo, T., Hallyburton, I., Anderson, M., Crespo‐Fernandez, B., Gamo, F., Antonova‐Koch, Y., Orjuela‐Sanchez, P., Wittlin, S., Jana, G. P., Maity, B. C., Chenu, E., Duffy, J., Sjö, P., Waterson, D., Winzeler, E., Guantai, E., Fidock, D. A., & Hansson, T. G. (2022). Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem, 17(22). Portico. https://doi.org/10.1002/cmdc.202200393

Lucchini, M., Zuraikat, F. M., & St-Onge, M.-P. (2022). Interrelationships Between Sleep, Obesity, and Glycemic Control in Children. Journal of the Endocrine Society, 7(1). https://doi.org/10.1210/jendso/bvac164

Zeidan, A. M., Platzbecker, U., Garcia-Manero, G., Sekeres, M. A., Fenaux, P., DeZern, A. E., Greenberg, P. L., Savona, M. R., Jurcic, J. G., Verma, A. K., Mufti, G. J., Buckstein, R., Santini, V., Shetty, J. K., Ito, R., Zhang, J., Zhang, G., Ha, X., Backstrom, J. T., & Komrokji, R. S. (2022). Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood, 140(20), 2170–2174. https://doi.org/10.1182/blood.2022016171

Hay, J. A., Kissler, S. M., Fauver, J. R., Mack, C., Tai, C. G., Samant, R. M., Connolly, S., Anderson, D. J., Khullar, G., MacKay, M., Patel, M., Kelly, S., Manhertz, A., Eiter, I., Salgado, D., Baker, T., Howard, B., Dudley, J. T., Mason, C. E., … Grad, Y. H. (2022). Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study. ELife, 11. CLOCKSS. https://doi.org/10.7554/elife.81849

Pan, Y., Wang, D., Chaudhary, M. F. A., Shao, W., Gerard, S. E., Durumeric, O. C., Bhatt, S. P., Barr, R. G., Hoffman, E. A., Reinhardt, J. M., & Christensen, G. E. (2022). Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS. Journal of Imaging, 8(11), 309. https://doi.org/10.3390/jimaging8110309

Naqvi, S. A. A., Fatima, S., Asghar, N., Ijaz, H., Ayaz, A., He, H., Husnain, M., Chakraborty, R., Riaz, I., & Aljama, M. A. (2022). Post Autologous Stem Cell Transplant Maintenance in Patients with Newly Diagnosed Multiple Myeloma: A Network Meta-Analysis. Blood, 140(Supplement 1), 10111–10113. https://doi.org/10.1182/blood-2022-170869

Li, S., Fu, J., Yang, J., Ma, H., Mapara, M. Y., Marcireau, C., & Lentzsch, S. (2022). MAP4K2 Inhibition Reinforces the Iberdomide Sensitivity in MM Cells By Inducing IKZF1 Degradation through a CRBN Independent Mechanism. Blood, 140(Supplement 1), 4224–4225. https://doi.org/10.1182/blood-2022-168314

Jacobsen, E. D., Zinzani, P. L., Zain, J., Mead, M., Casulo, C., Gritti, G., Pinter-Brown, L. C., Izutsu, K., Daugherty, M., Brammer, J. E., Mehta-Shah, N., Pro, B., & Horwitz, S. M. (2022). Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial Expansion Phase: Impact of Prior Treatment and Expanded Safety Analysis. Blood, 140(Supplement 1), 9387–9389. https://doi.org/10.1182/blood-2022-169432

Mohyuddin, G. R., Chakraborty, R., Calip, G., Ascha, M. S., Wang, X., Rubinstein, S., Tuchman, S. A., Costa, L. J., Haaland, B., Giri, S., Mian, H. S., Fonseca, R., & Sborov, D. W. (2022). Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy. Blood, 140(Supplement 1), 5223–5224. https://doi.org/10.1182/blood-2022-165541

Orlando, E., Ford, M., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation. Blood, 140(Supplement 1), 12085–12086. https://doi.org/10.1182/blood-2022-158050

Bumma, N., Richter, J., Brayer, J., Zonder, J. A., Dhodapkar, M., Shah, M. R., Hoffman, J. E., Mawad, R., Maly, J. J., Lentzsch, S., Suvannasankha, A., Roy, P., Dey, J., Chokshi, D., Boyapati, A., Visich, J., Houvras, Y., Rodriguez Lorenc, K., Kroog, G. S., & Jagannath, S. (2022). Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study. Blood, 140(Supplement 1), 10140–10141. https://doi.org/10.1182/blood-2022-159969

Chakraborty, R., Sexton, R., Lentzsch, S., Abidi, M. H., Voorhees, P. M., Cohen, A. D., Rohren, E., Heitner, S. B., Kelly, K. R., Mackler, N. J., Baer, D. M., Hoering, A., Durie, B. G. M., Ailawadhi, S., & Orlowski, R. Z. (2022). Renal Toxicity with Carfilzomib in Multiple Myeloma: Secondary Analysis of SWOG S1304 Comparing Low-Dose Versus High-Dose Carfilzomib. Blood, 140(Supplement 1), 4349–4351. https://doi.org/10.1182/blood-2022-166609

Estrella, B., Pazos, M. A., Ricker, E. C., Ryu, Y. K., Piorczynski, T. B., Liu, Y., Tolu, S., & Amengual, J. E. (2022). First-in-Class Histone Acetyltransferase (HAT) Activator, YF2, Modulates Immune Evasion in DLBCL, Enhancing the Effects of Immune Checkpoint Blockade. Blood, 140(Supplement 1), 358–359. https://doi.org/10.1182/blood-2022-166929

Lee, H. J., Choi, M. Y., Siddiqi, T., Rhodes, J. M., Wierda, W. G., Isufi, I., Tuscano, J. M., Lamanna, N., Subbiah, S., Koff, J. L., Leslie, L., Goldenberg, A., Chung, G. G., Breitmeyer, J. B., Yazji, S., Wang, M., Jamieson, C., & Kipps, T. J. (2022). Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL). Blood, 140(Supplement 1), 566–568. https://doi.org/10.1182/blood-2022-167153

Mosialou, I., Ali, A. M., Adams, R., Corper, A., Woods, C. M., Fan, X., Raza, A., & Kousteni, S. (2022). Therapeutic Anti-Jagged1 Antibody Targeting Osteoblast-Related Myeloid Dysplasia to Overcome Standard of Care Resistance. Blood, 140(Supplement 1), 2902–2902. https://doi.org/10.1182/blood-2022-167042